Your browser doesn't support javascript.
loading
The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1.
Oze, T; Hiramatsu, N; Yakushijin, T; Yamada, R; Harada, N; Morishita, N; Oshita, M; Mita, E; Ito, T; Inui, Y; Inada, M; Tamura, S; Yoshihara, H; Imai, Y; Kato, M; Miyagi, T; Yoshida, Y; Tatsumi, T; Kasahara, A; Hayashi, N; Takehara, T.
Affiliation
  • Oze T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
J Viral Hepat ; 22(3): 254-62, 2015 Mar.
Article de En | MEDLINE | ID: mdl-25081140

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oligopeptides / Polyéthylène glycols / Ribavirine / Interféron alpha / Hepacivirus / Hépatite C chronique / Génotype Type d'étude: Etiology_studies / Observational_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Viral Hepat Sujet du journal: GASTROENTEROLOGIA Année: 2015 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oligopeptides / Polyéthylène glycols / Ribavirine / Interféron alpha / Hepacivirus / Hépatite C chronique / Génotype Type d'étude: Etiology_studies / Observational_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Viral Hepat Sujet du journal: GASTROENTEROLOGIA Année: 2015 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni